Robotic pancreaticoduodenectomy: Where do we stand?

Table 1 Outcomes of robotic pancreaticoduodenectomy in selected studies

Ref.	n	OR time (mean in min)	EBL (mean in mL)	Conversion (%)	R0 (%)	LN harvest (mean)	Fistula (%)	Morbidity (%)	Mortality (%)	LOS (mean in days)
Giulianotti et al[28], 2010	60	421	394	18.3	82	18	31.6	NR	3.3	22
Narula et al[29], 2010	5	420	NR	37.5	100	16	0	0	0	9.6
Zhou et al[30], 2011	8	718	153	0	100	NR	25	NR	0	16.4
Lai et al[31], 2012	20	491.5	247	5	73.3	10	35	50	0	13.7
Chalikonda et al[32], 2012	30	476	485	10	100	13.2	6.6	30	3	9.8
Bao et al[33], 2014	28	431	100	14	88	15	29	NR	2	7.4
Boone et al[34], 2015	200	483	250	6.5	92	22	17	67.5	3.3	9
Chen et al[26], 2015	60	410	400	1.7	97.8	13.6	13.3	35	1.7	20
Boggi et al[35], 2016	83	527	NR	1.5	NR	37	33.7	73.5	3	17
Nassour et al[36], 2017	193	399	NR	11.4	NR	NR	20.8	54.9	1	8
Jin et al[37], 2020	17	240	100	0	NR	4	59	66.4	NR	15
Mejia et al[38], 2020	102	352	321	12.7	73	24.2	3.9	31.3	2.9	7
Shi et al[39], 2020	187	279	297	3.7	94	16.6	10.2	35.6	2.1	22.4
Zureikat et al[23], 2021	500	415	250	5.2	85	28	20.2	68.8	1.8	8

EBL: Estimated blood loss; LN: Lymph node; LOS: Length of stay; NR: Not reported; OR: Operation; R0: Margin negative resection.